NASDAQ

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

MELBOURNE, Australia and DRESDEN, Germany, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited ...

Immunomedics Highlights Expanded Pipeline Positioning Company for Sustained Value Creation

-- Details Preclinical and Clinical Progress in Advancing IMMU-114, IMMU-130, IMMU-140, and Immuno-Oncology Program ...

Immunomedics Announces New Data for IMMU-132 at Investor R&D Day

-- IMMU-132 Provides Opportunity for Significant Near-Term Value Creation -- -- Submission for Accelerated ...

Celsion Corporation Announces Issuance of Two New Patents for ThermoDox®

LAWRENCEVILLE, N.J., Jan. 18, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical stage ...